Arcturus Therapeutics Ltd (NASDAQ:ARCT)

6.10
Delayed Data
As of May 25
 -0.1036 / -1.67%
Today’s Change
4.78
Today|||52-Week Range
15.19
-23.27%
Year-to-Date
No recent news for Arcturus Therapeutics Ltd.

Today’s Trading

Previous close6.20
Today’s open6.14
Day’s range6.05 - 6.31
Volume16,108
Average volume (3 months)50,914
Market cap$59.9M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+87.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
RCKTRocket Pharmaceutica...+0.04+0.20%
TNXPTonix Pharmaceutical...-0.01-0.32%
VICLVical Inc+0.03+1.83%
SESNSesen Bio Inc-0.30-14.71%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateMay 29, 2018
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President
Mark R. Herbert
Vice President-Finance &
Operations
Rebecque J. Laba
Corporate headquarters
San Diego, California

Forecasts